- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00582361
Vacuum Assisted Closure as a Treatment for Open Fractures (VAC-OF)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Soft tissue injury following an open fracture is a significant problem following surgical treatment of traumatic skeletal injuries. The soft tissue injury results from a combination of the initiating trauma and additional tissue injury during surgery. Current treatment includes open reduction and internal fixation versus external fixation, irrigation and debridement following admission, decreased activity (non weight bearing status on the injured extremity), maintaining the patient as an inpatient in the hospital, repeated irrigation and debridements (36-72 hours following the initial trauma) with concomitant wound culturing until which time it is determined that either delayed primary closure, or skin grafting with/without flap coverage should be attempted.
All patients in the study will be treated with the appropriate empiric antibiotic regimen until wound culture results justify modification for antibiotic sensitivity/resistance reasons. In general, barring patient allergy, the empiric antibiotic regimen will adhere to the Gustilo and Anderson classification as follows:
Grade I : Ancef Grade II : Ancef and Gentamicin or Zosyn Grade III : Ancef, Gentamicin or Zosyn, and add a Penicillin for grade IIIB open fractures.
All wounds will be assessed initially at admission following the Gustilo and Anderson classification for open fractures. Subsequent wound assessments in the operating room will be graded according to the following descriptive scale:
Type A wound: Abundant granulation tissue, ready for closure. Type B Wound: Granulation tissue present but inadequate for closure, Wound is clinically clean appearing. Type C Wound: No granulation tissue, no gross purulence. Type D Wound: Gross purulence/infected wound, no granulation tissue.
The outcome variables consist of the intraoperative and postoperative adverse device effects recorded in the medical record and on the study data collection form, time to wound closure, intraoperative and postoperative complications recorded in medical record and on the study data collection form. Clinical photographs of the wounds will be taken with a digital camera at the time of admission to the study, and during each subsequent trip to the operating room (every 48-72 hours). We will also record the injury severity score for all multiple trauma patients recorded at the time of injury in the medical record and on the study data collection form, and soft tissue score according to Gustillo and Anderson for open injuries in the medical record and on the study data collection form. Baseline serum albumin and total lymphocyte counts will be taken on admission to evaluate baseline nutritional and immunologic status at the time of injury. All patients in the Intensive Care Units will have daily weights, fluid balances, and nutritional intake documented. Resuscitation data will also be recorded from the trauma room, including fluids, blood, and base deficit. The effects will be measured by clinical examination and will be augmented with culture data for any wounds that require surgical intervention.
Patients who have an open fracture and who give informed consent to enter the study will be randomized into two groups. Group A will be patients treated with a return to the operating room approximately 48 hours following the initial trauma, and approximately every 48 hours thereafter, for irrigation and debridement and concomitant wound cultures (qualitative and quantitative) until which time the wound is judged by the surgeon to be ready for either delayed primary closure or flap/skin graft coverage. Group B will be patients treated with a VAC negative pressure device following the initial surgical irrigation and debridement. Group B patients will return to the operating room approximately 48 hours following the initial irrigation and debridement for VAC removal, wound cultures (qualitative and quantitative), repeat irrigation and debridement, and wound evaluation by the surgeon for possible delayed closure versus reapplication of the VAC device. Group B patients will also be returned to the operating room approximately every 48 hours thereafter for irrigation and debridement and concomitant wound cultures (qualitative and quantitative) until the wound is judged ready for coverage or closure by the surgeon.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35294
- The University of Alabama at Birmingham, Orthopaedic Trauma
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patient who has sustained an open fracture that requires surgical irrigation and debridement.
- No gross clinical evidence of infection.
Exclusion Criteria:
- A grossly infected open wound. Infection will be defined by clinical signs and symptoms of infection that include increasing drainage, increasing pain, purulent drainage, and increasing erythema. Any wounds that are thought to be infected will be cultured to confirm the diagnosis.
- A surgical incision that can not be covered with VAC sponges and a water impermeable sheet (such as Ioban or Tegaderm) to achieve a closed vacuum environment over the wound.
- Wounds associated with the surgical incision that are intentionally left open to heal with either a delayed primary closure or secondary granulation
- Abnormal coagulation leading to an expanding hematoma that will require surgical debridement.
- Pregnant women.
- Inability or unwillingness to comply with protocol.
- Patients or family members who are unable or unwilling to sign study informed consent.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: 1, A
Group A patients will have a standard dressing applied following initial treatment of their open fracture.
|
Group A patients will have a standard dressing applied following initial treatment of their open fracture.
They will return to the operating room approximately 48 hours following the initial trauma, and approximately every 48 hours thereafter, for irrigation and debridement and concomitant wound cultures (qualitative and quantitative) until such time as the wound is judged by the surgeon to be ready for either delayed primary closure or flap/skin graft coverage.
|
Experimental: 2, B
Group B patients will have a Vacuum Assisted Closure (VAC) device applied following initial treatment of their open fracture.
|
Group B patients will have a Vacuum Assisted Closure (VAC) device applied following initial treatment of their open fracture.
They will return to the operating room approximately 48 hours following the initial trauma, and approximately every 48 hours thereafter, for irrigation and debridement and concomitant wound cultures (qualitative and quantitative) until such time as the wound is judged by the surgeon to be ready for either delayed primary closure or flap/skin graft coverage.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Healing of Orthopaedic Trauma Open Fractures
Time Frame: from surgery to wound closure
|
Healing of the open wound following orthopaedic trauma open fracture surgery was measured in days.
(The wound has healed adequately to permit closure)
|
from surgery to wound closure
|
Infections
Time Frame: Up to 12 months
|
Number of acute, delayed and deep wound infections.
|
Up to 12 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Rena L Stewart, MD, The University of Alabama at Birmingham
Publications and helpful links
General Publications
- Parrett BM, Matros E, Pribaz JJ, Orgill DP. Lower extremity trauma: trends in the management of soft-tissue reconstruction of open tibia-fibula fractures. Plast Reconstr Surg. 2006 Apr;117(4):1315-22; discussion 1323-4. doi: 10.1097/01.prs.0000204959.18136.36.
- Steiert AE, Partenheimer A, Schreiber T, Muehlberger T, Krettek C, Lahoda LU, Vogt PM. [The V.A.C. system (vacuum assisted closure) as bridging between primary osteosynthesis in conjunction with functional reconstructed of soft tissue--open fractures type 2 and type 3]. Zentralbl Chir. 2004 May;129 Suppl 1:S98-100. doi: 10.1055/s-2004-822658. German.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- F010316004
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Orthopaedic Traumatic Open Fractures
-
Mohammed Ghassan Mohammed ShaalanEnrolling by invitationOrbital Floor (Blow-Out) Open Fracture | Enophthalmos TraumaticEgypt
-
Massachusetts General HospitalEnrolling by invitationNon-traumatic and Traumatic Orthopaedic IssuesUnited States
-
University of Alabama at BirminghamSynthes Inc.CompletedOrthopaedic Trauma Fractures and Non-unionsUnited States
-
Olayemi Osiyemi MDForest LaboratoriesUnknown
-
PolyPid Ltd.CompletedTibial Fractures | Open FracturesIsrael, Philippines
-
Major Extremity Trauma Research ConsortiumCompletedOrthopaedic FracturesUnited States
-
National Institute of Arthritis and Musculoskeletal...Terminated
-
Assiut UniversityNot yet recruitingOpen tíbia Fracture
-
Major Extremity Trauma Research ConsortiumUnited States Department of DefenseCompletedSevere Open Fractures of the Tibia (Shin) BoneUnited States
-
Assiut UniversityNot yet recruiting
Clinical Trials on Standard Wound Dressing
-
Community Pharmacology Services LtdKeneric HealthcareNot yet recruitingDiabetic Foot Ulcer | Diabetic Foot Ulcer Neuropathic | Diabetic Foot Ulcer Ischemic
-
University Hospital of LimerickCompleted
-
Indiana UniversityCompletedHypertrophic Skin Condition of Anterior AbdomenUnited States
-
Tufts Medical CenterTerminatedObesity | Surgical Site Infections | Complications; Cesarean Section | Wound ComplicationsUnited States
-
Royal College of Surgeons, IrelandNot yet recruitingWound Infection | Cosmesis | Wound Surgical
-
Northwell HealthCompletedCesarean Section Complications | Cesarean Wound Disruption | Cesarean Wound; DehiscenceUnited States
-
Kristian Kiim JensenNot yet recruitingQuality of Life | Surgical Wound Infection | Surgical Site Infection | Incisional HerniaDenmark
-
Mayo Clinic3MCompletedSurgical Wound InfectionUnited States
-
London Health Sciences CentreUnknownInfection | Amputation Wound | Amputation Stump Complication | Amputation Stump; Infection
-
Chinese University of Hong KongRecruitingKnee Arthropathy | Negative Pressure Wound Therapy | Hip ArthropathyHong Kong